These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 3145201)

  • 1. Synthesis, cloning and expression in Escherichia coli of artificial genes coding for biologically active elongated precursors of the vasoactive intestinal polypeptide.
    Simoncsits A; Tjörnhammar ML; Kalman M; Cserpan I; Gafvelin G; Bartfai T
    Eur J Biochem; 1988 Dec; 178(2):343-50. PubMed ID: 3145201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression and transcript size of the prepro-peptide VIP/PHM-27 in normal human tissue.
    Schulte-Bockholt A; Meier DA; Hopp K; Stadelmann A; Otterson MF; Telford GL; Koch TR
    Neurosci Lett; 1993 Dec; 164(1-2):101-4. PubMed ID: 8152582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ hybridization reveals VIP precursor mRNA-containing neurons in monkey and rat neocortex.
    Benson DL; Isackson PJ; Jones EG
    Brain Res Mol Brain Res; 1991 Jan; 9(1-2):169-74. PubMed ID: 1850073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence of a cDNA encoding chicken vasoactive intestinal peptide (VIP).
    McFarlin DR; Lehn DA; Moran SM; MacDonald MJ; Epstein ML
    Gene; 1995 Mar; 154(2):211-3. PubMed ID: 7890166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and expression of the gene encoding the vasoactive intestinal peptide precursor.
    Linder S; Barkhem T; Norberg A; Persson H; Schalling M; Hökfelt T; Magnusson G
    Proc Natl Acad Sci U S A; 1987 Jan; 84(2):605-9. PubMed ID: 3025882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production, analysis and bioactivity of recombinant vasoactive intestinal peptide analogs.
    Raingeaud J; Lavergne F; Lelievre V; Muller JM; Julien R; Cenatiempo Y
    Biochimie; 1996; 78(1):14-25. PubMed ID: 8725006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide: expression of the prohormone in bacterial cells.
    DeLamarter JF; Buell GN; Kawashima E; Polak JM; Bloom SR
    Peptides; 1985; 6 Suppl 1():95-102. PubMed ID: 2995945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a potential receptor for both peptide histidine isoleucine and peptide histidine valine.
    Tse DL; Pang RT; Wong AO; Chan SM; Vaudry H; Chow BK
    Endocrinology; 2002 Apr; 143(4):1327-36. PubMed ID: 11897689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of the human vasoactive intestinal polypeptide gene.
    Tsukada T; Horovitch SJ; Montminy MR; Mandel G; Goodman RH
    DNA; 1985 Aug; 4(4):293-300. PubMed ID: 3899557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27.
    Itoh N; Obata K; Yanaihara N; Okamoto H
    Nature; 1983 Aug 11-17; 304(5926):547-9. PubMed ID: 6571696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete nucleotide sequence of human vasoactive intestinal peptide/PHM-27 gene and its inducible promoter.
    Yamagami T; Ohsawa K; Nishizawa M; Inoue C; Gotoh E; Yanaihara N; Yamamoto H; Okamoto H
    Ann N Y Acad Sci; 1988; 527():87-102. PubMed ID: 2839091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a VIP-specific receptor in guinea pig tenia coli.
    Teng BQ; Grider JR; Murthy KS
    Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G718-25. PubMed ID: 11518684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for common precursors but differential processing of VIP and PHM in VIP-producing tumors.
    Fahrenkrug J
    Peptides; 1985; 6(3):357-61. PubMed ID: 3840886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide receptor chimeras reveal domains that determine specificity of vasoactive intestinal polypeptide binding and activation.
    Hashimoto H; Ogawa N; Hagihara N; Yamamoto K; Imanishi K; Nogi H; Nishino A; Fujita T; Matsuda T; Nagata S; Baba A
    Mol Pharmacol; 1997 Jul; 52(1):128-35. PubMed ID: 9224822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal polypeptide precursors have highly potent bronchodilatory activity.
    Ito O; Tachibana S
    Peptides; 1991; 12(1):131-7. PubMed ID: 2052489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of a variant form of vasoactive intestinal polypeptide.
    Gafvelin G; Andersson M; Dimaline R; Jörnvall H; Mutt V
    Peptides; 1988; 9(3):469-74. PubMed ID: 2843830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleotide sequence divergence and functional constraint in VIP precursor mRNA evolution between human and rat.
    Nishizawa M; Hayakawa Y; Yanaihara N; Okamoto H
    FEBS Lett; 1985 Apr; 183(1):55-9. PubMed ID: 3838518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentrations and distribution of vasoactive intestinal peptide (VIP), peptide histidine isoleucine (PHI) and peptide histidine valine (PHV) in the cerebral cortex and the suprachiasmatic nucleus of the mouse.
    Mikkelsen JD; Fahrenkrug J
    Brain Res; 1994 Sep; 656(1):95-107. PubMed ID: 7804850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VIP and PHI in the pig pancreas: coexistence, corelease, and cooperative effects.
    Holst JJ; Fahrenkrug J; Knuhtsen S; Jensen SL; Nielsen OV; Lundberg JM; Hökfelt T
    Am J Physiol; 1987 Feb; 252(2 Pt 1):G182-9. PubMed ID: 3548423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.